Efficacy of enhanced extracorporeal counterpulsation combined with atorvastatin in the treatment of cognitive impairment after stroke

Figure 1 Comparison of the level of each observation index between the two groups. A: Comparison of neurotransmitter levels between the two groups; B: Comparison of neurotransmitter levels between the two groups; C: Comparison of vascular endothelial function markers between the two groups; D: Evaluation of serum levels of β2-microglobulin, visinin-like protein 1, and glial fibrillary acidic protein between the two groups; E: Comparison of pulsatility index values of the cerebral vasculature between the two groups; F: Analyzing the difference in resistance index values of the cerebral vessels between the two groups. MMSE: Mini-Mental State Examination; MoCA: Montreal Cognitive Assessment; ADL: Activities of daily living; Ach: Acetylcholine; AChE: Acetylcholinesterase; NO: Nitric oxide; ET-1: Endothelin-1; β2-MG: β2-microglobulin; GFAP: Glial fibrillary acidic protein; VILIP-1: Visinin-like protein 1; LACA: Left-anterior cerebral artery; RACA: Right-anterior cerebral artery; LMCA: Left-middle cerebral artery; RMCA: Right-middle cerebral artery; LPCA: Left-posterior cerebral artery; RPCA: Right-posterior cerebral artery. ^aP < 0.05.